[1]
2026. A Review on Pharmacology and Resistance Mechanisms for Sunvozertinib in EGFR Exon 20 Insertion–Mutant Non-Small Cell Lung Cancer: Review Article. Journal of Pharma Insights and Research. 4, 4 (Aug. 2026), 160–178. DOI:https://doi.org/10.69613/29bezg03.